News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

A. Georgii

Articles by A. Georgii

Increased Efficacy Through Moderate Dose Escalation of Chemotherapy: Interim Report From the HD9 Randomized Trial for Advanced Hodgkin’s Disease

ByV. Diehl,J. Franklin,M. Sieber,D. Hasenclever,U. Paulus,H. Tesch,M. Pfreundschuh,U. Rüffer,R. Hermann,C. Longin,M. Hänel,G. Wulf,W. Aulitzky,A. Georgii,E. Dühmke,M. Loeffler

March 1st 1999

This report aims to assess the effect of increased drug dose on the efficacy and toxicity of the BEACOPP regimen with

Latest Updated Articles

Increased Efficacy Through Moderate Dose Escalation of Chemotherapy: Interim Report From the HD9 Randomized Trial for Advanced Hodgkin’s Disease
March 1st 1999

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Accepts sNDA for Taletrectinib in ROS1-Positive NSCLC

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

TIP127 TroFuse-012: A Phase 3, Randomized Study of Adjuvant Sacituzumab Tirumotecan Plus Pembrolizumab Vs Treatment of Physician’s Choice in Participants With Triple-Negative Breast Cancer who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response at Surgery